Kangmei Pharma | 600518 - Operating Expenses


Kangmei Pharma reported CNY1.09B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.01M 175K Mar/2026
Avita Medical AUD 28.02M 1.55M Dec/2025
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Dianthus Therapeutics USD 47M 22.83M Mar/2026
Genomma Lab Internacional MXN 3.52B 203.63M Jun/2026
Hypermarcas BRL 1.51B 77.98M Mar/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
Jiangsu Hengrui CNY 5.56B 39.12M Jun/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Moderna USD 960M 817M Jun/2026
Organon & Co USD 1.01B 103M Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
Sh Fosun Pharma CNY 9.72B 542.18M Jun/2026
Tectonic Therapeutic USD 27.3M 5.78M Mar/2026
Viatris USD 3.68B 145.9M Jun/2026
Wuxi Apptec CNY 8.49B 1.16B Jun/2026
Xeris Pharmaceuticals USD 75.21M 6.18M Mar/2026
Zz Pientze Pharmaceu CNY 1.45B 431.06M Jun/2026